Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer
- PMID: 35864239
- DOI: 10.1007/s10120-022-01321-w
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer
Abstract
Background: Oncologic outcomes after laparoscopic gastrectomy for advanced gastric cancer in the West have been poorly investigated. The aim of the present study was to compare survival outcomes in patients undergoing curative-intent laparoscopic and open gastrectomy for advanced gastric cancer in several centres belonging to the Italian Research Group for Gastric Cancer.
Methods: Data of patients operated between 2015 and 2018 were retrospectively analysed. Propensity Score Matching was performed to balance baseline characteristics of patients undergoing laparoscopic and open gastrectomy. The primary endpoint was 3-year overall survival. Secondary endpoints were 3-year disease-free survival and short-term outcomes. Multivariable regression analyses for survival were conducted.
Results: Data were retrieved from 20 centres. Of the 717 patients included, 438 patients were correctly matched, 219 per group. The 3-year overall survival was 73.6% and 68.7% in the laparoscopic and open group, respectively (p = 0.40). When compared with open gastrectomy, laparoscopic gastrectomy showed comparable 3-year disease-free survival (62.8%, vs 58.9%, p = 0.40), higher rate of return to intended oncologic treatment (56.9% vs 40.2%, p = 0.001), similar 30-day morbidity/mortality. Prognostic factors for survival were ASA Score ≥ 3, age-adjusted Charlson Comorbidity Index ≥ 5, lymph node ratio ≥ 0.15, p/ypTNM Stage III and return to intended oncologic treatment.
Conclusions: Laparoscopic gastrectomy for advanced gastric cancer offers similar rates of survival when compared to open gastrectomy, with higher rates of return to intended oncologic treatment. ASA score, age-adjusted Charlson Comorbidity Index, lymph node ratio, return to intended oncologic treatment and p/ypTNM Stage, but not surgical approach, are prognostic factors for survival.
Keywords: Advanced gastric cancer; Gastrectomy; Laparoscopy; Minimally invasive surgery; Survival.
© 2022. The Author(s) under exclusive licence to The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
Similar articles
-
Laparoscopic vs. Open Gastrectomy for Locally Advanced Gastric Cancer: A Propensity Score-Matched Retrospective Case-Control Study.Curr Oncol. 2022 Mar 9;29(3):1840-1865. doi: 10.3390/curroncol29030151. Curr Oncol. 2022. PMID: 35323351 Free PMC article.
-
Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study.J Clin Oncol. 2014 Mar 1;32(7):627-33. doi: 10.1200/JCO.2013.48.8551. Epub 2014 Jan 27. J Clin Oncol. 2014. PMID: 24470012
-
The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.Surg Endosc. 2017 Mar;31(3):1383-1392. doi: 10.1007/s00464-016-5126-0. Epub 2016 Jul 22. Surg Endosc. 2017. PMID: 27450211
-
The Advances of Laparoscopic Gastrectomy for Gastric Cancer.Gastroenterol Res Pract. 2017;2017:9278469. doi: 10.1155/2017/9278469. Epub 2017 Sep 5. Gastroenterol Res Pract. 2017. PMID: 29018482 Free PMC article. Review.
-
KLASS (Korean Laparoendoscopic Gastrointestinal Surgery Study Group) trials: a 20-year great journey in advancing surgical clinical research for gastric cancer.Ann Surg Treat Res. 2025 Jan;108(1):1-11. doi: 10.4174/astr.2025.108.1.1. Epub 2025 Jan 7. Ann Surg Treat Res. 2025. PMID: 39823037 Free PMC article. Review.
Cited by
-
Survival Outcomes Between Minimally Invasive and Open Gastrectomy in Early and Locally Advanced Gastric Adenocarcinoma in a Western Center.J Gastrointest Cancer. 2025 Feb 20;56(1):68. doi: 10.1007/s12029-024-01163-y. J Gastrointest Cancer. 2025. PMID: 39979489
-
Short- and long-term outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy: A case-control study using a propensity score matching method.Surg Open Sci. 2023 Oct 6;16:111-120. doi: 10.1016/j.sopen.2023.10.001. eCollection 2023 Dec. Surg Open Sci. 2023. PMID: 37840945 Free PMC article.
-
Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study.BMC Cancer. 2023 Sep 28;23(1):916. doi: 10.1186/s12885-023-11374-4. BMC Cancer. 2023. PMID: 37770842 Free PMC article.
-
Gastric Cancer Surgery: Balancing Oncological Efficacy against Postoperative Morbidity and Function Detriment.Cancers (Basel). 2024 Apr 29;16(9):1741. doi: 10.3390/cancers16091741. Cancers (Basel). 2024. PMID: 38730693 Free PMC article. Review.
-
ASO Author Reflections: Enhancing Return to Intended Oncologic Therapy in Gastric Cancer-The Role of Minimally Invasive Gastrectomy.Ann Surg Oncol. 2025 Feb;32(2):1257-1258. doi: 10.1245/s10434-024-16517-w. Epub 2024 Nov 18. Ann Surg Oncol. 2025. PMID: 39556175 No abstract available.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. - DOI
-
- Sitarz R, Skierucha M, Mielko J, Offerhaus J, Maciejewski R, Polkowski W. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018. https://doi.org/10.2147/cmar.s149619 . - DOI - PubMed - PMC
-
- Griffin SM. Gastric cancer in the East: same disease, different patient. Br J Surg. 2005;92:1055–6. - DOI
-
- Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27–39. - DOI
-
- Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet Elsevier BV. 2019;393:1948–57. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical